1. Home
  2. SHOT vs AKTX Comparison

SHOT vs AKTX Comparison

Compare SHOT & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHOT
  • AKTX
  • Stock Information
  • Founded
  • SHOT 2018
  • AKTX N/A
  • Country
  • SHOT United States
  • AKTX United States
  • Employees
  • SHOT N/A
  • AKTX N/A
  • Industry
  • SHOT Biotechnology: Pharmaceutical Preparations
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHOT Health Care
  • AKTX Health Care
  • Exchange
  • SHOT Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • SHOT 31.4M
  • AKTX 32.8M
  • IPO Year
  • SHOT 2020
  • AKTX N/A
  • Fundamental
  • Price
  • SHOT $0.53
  • AKTX $1.24
  • Analyst Decision
  • SHOT
  • AKTX
  • Analyst Count
  • SHOT 0
  • AKTX 0
  • Target Price
  • SHOT N/A
  • AKTX N/A
  • AVG Volume (30 Days)
  • SHOT 750.8K
  • AKTX 25.4K
  • Earning Date
  • SHOT 03-31-2025
  • AKTX 02-15-2025
  • Dividend Yield
  • SHOT N/A
  • AKTX N/A
  • EPS Growth
  • SHOT N/A
  • AKTX N/A
  • EPS
  • SHOT N/A
  • AKTX N/A
  • Revenue
  • SHOT $652,495.00
  • AKTX N/A
  • Revenue This Year
  • SHOT N/A
  • AKTX N/A
  • Revenue Next Year
  • SHOT N/A
  • AKTX N/A
  • P/E Ratio
  • SHOT N/A
  • AKTX N/A
  • Revenue Growth
  • SHOT 68.01
  • AKTX N/A
  • 52 Week Low
  • SHOT $0.45
  • AKTX $0.90
  • 52 Week High
  • SHOT $4.05
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • SHOT 43.17
  • AKTX 51.97
  • Support Level
  • SHOT $0.45
  • AKTX $1.10
  • Resistance Level
  • SHOT $0.52
  • AKTX $1.39
  • Average True Range (ATR)
  • SHOT 0.05
  • AKTX 0.13
  • MACD
  • SHOT 0.01
  • AKTX -0.00
  • Stochastic Oscillator
  • SHOT 59.06
  • AKTX 61.54

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Share on Social Networks: